2 Massachusetts Cities Have Decriminalized Psychedelics in the Last Month
Two Massachusetts cities have decriminalized psychedelics since the start of 2021. Cambridge and Somerville say the benefits outweigh the risks.
Entries by
The World’s First Psychedelic ETF Just Launched: Here’s Why That Matters
The Horizons Psychedelic ETF launched on the Canadian NEO stock exchange last month. Here’s what that means for the industry, and the future.
Psychedelic Business News Spotlight: January 29, 2021
This week in psychedelic business news, Psyence Group’s psilocybin harvest, NeonMind’s new CEO, and Mydecine sponsors new research.
Hawaii Moves to Legalize Psilocybin Treatment
Hawaii may soon legalize psilocybin therapy for the treatment of a range of mental health issues, according to proposed legislation.
Psychedelic Business News Spotlight: January 22, 2021
This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and funds.
Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research
Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.
Psychedelic Business News Spotlight: January 15, 2021
This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
Is America Ready for Psilocybin Mushroom Retreats?
With Oregon’s recent victory for psychedelics, psilocybin retreats could soon be commonplace. What does that mean for mental health treatment?
Psychedelic Business News Spotlight: January 08, 2021
This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
NeonMind Takes Psilocybin Therapy Public
NeonMind is the latest psychedelic company to go public. It’s the first to launch on the Canadian Stock Exchange in 2021.
